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What makes it work? Exploring experiences
of patient research partners and
researchers involved in a long-term
co-creative research collaboration
Emma Hovén1* , Lars Eriksson2,3,4, Åsa Månsson D’Souza5, Johanna Sörensen5, David Hill5, Carolin Viklund5,
Lena Wettergren1† and Claudia Lampic1,6†
Abstract
Background: Exchanging experiences of patient and public involvement (PPI) can bring insights into why, how
and when PPI is most effective. The aim of this study was to explore the experiences of patient research partners
(PRPs) and researchers engaged in a co-creative long-term collaboration in cancer research.
Methods: The aim and procedures of this study were jointly decided upon by PRPs and researchers. The PRPs
included former patients treated for cancer and significant others of the same target group. The participants (11
PRPs, 6 researchers) took part in semi-structured telephone interviews. The interviews were analysed using
qualitative content analysis by a researcher who had no prior relationships with the participants.
Results: Five overarching categories were identified: Reasons for investing in a long-term collaboration, Benefits of
participating, Improving the research, Elements of success and Challenges and ways to improve. Reasons for investing
in the collaboration included the desire to improve cancer care and to make use of own negative experiences.
Benefits of participating included a positive impact on the PRPs’ psychosocial adjustment to the illness. Moreover,
the researchers highlighted that working together with the PRPs made the research feel more meaningful. The
participants reported that the collaboration improved the relevance and acceptability of the research. Having a
shared goal, a clear but yet accommodating structure, as well as an open and trustful working atmosphere were
recognised as elements of success. The PRPs furthermore emphasized the importance of seeing that their input
mattered. Among the few challenges raised were the distance to the meeting venues for some PRPs and a limited
diversity among participants.
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Conclusions: This study identified factors essential to researchers and clinicians attempting to engage the public in
research. Our results suggest that for successful patient involvement, the purpose and format of the collaboration
should be clear to both PRPs and researchers. A clear but yet accommodating structure and keen leadership
emerged as key factors to create a sense of stability and a trustful atmosphere. Furthermore, providing regular
feedback on how PRPs input is implemented is important for PRPs to stay committed over time.
Keywords: Patient and public involvement, Co-creative long-term collaboration, Patient research partners, Cancer research,
Plain English Summary
Exchanging experiences of patient and public involvement
(PPI) can bring insights into why, how and when PPI in
research brings the greatest benefits. The aim of this study
was to explore the experiences of patient research partners
(PRPs) and researchers engaged in a co-creative long-term
collaboration in cancer research. The PRPs included
former patients treated for cancer and significant others of
former patients. Participants (11 PRPs, 6 researchers) took
part in semi-structured telephone interviews. The analysis
identified five overarching categories: Reasons for investing
in a long-term collaboration, Benefits of participating,
Improving the research, Elements of success and Challenges
and ways to improve. Reasons for investing in the collab-
oration included the desire to improve care and to make
use of own negative experiences. The participants recog-
nised personal benefits of taking part in the collaboration,
including that participating had been therapeutic. Positive
impact of involvement on the research was also acknowl-
edged. For example, the participants reported that the col-
laboration made the research more relevant, acceptable
and tailored to end users. Among the most prominent ele-
ments of success reported by the participants were having
a shared goal, a clear but yet accommodating structure, an
open and trustful working atmosphere, and seeing that
input made a difference. Among the few challenges raised
were distance to the meeting venues and limited diversity
among the participants. Altogether, the results inform
researchers attempting to engage patients in research by
describing factors that should be considered when plan-
ning and working with PRPs.
Introduction
Patient and public involvement (PPI) in health and
social care research has been reported increasingly over
the last decades, and is now regarded as an integral part
of good scientific practice [1]. PPI has been defined by
the National Institute for Health Research patient and
public involvement advisory group, as ‘research being
carried out with or by members of the public, rather
than to, about or for them’ [2]. The rationale for public
involvement in research is that it can enhance the qual-
ity, relevance, and uptake of research. More specifically,
to incorporate a patient and public perspective may
benefit study feasibility and deliverability by ensuring
that research objectives, information and measures are
relevant and user-friendly [3–6]. Involving patients and
the public can also make the research more ethical
(e.g., by improving the consent process and the accept-
ability of the research) and improve dissemination of
research to study participants and the wider community
[4]. Despite an increasing interest in public involve-
ment, there is still a relatively weak evidence base for
the impact of PPI in health research [3, 7–9]. Further-
more, there is currently no consensus available on PPI
best practice [10]. While PPI is well established in the
United Kingdom (UK), North America and Australia, a
recent systematic review of PPI publications in cancer
research concluded that other countries are still in its
early stages [11]. From a Nordic perspective,
researchers have indicated a need for building a better
understanding of the concept in order to increase and
enhance PPI in health research [12].
Studies on the impact of PPI on patient and public
representatives themselves have reported both positive
and negative experiences (e.g., [13–16]). Reported bene-
fits of patient involvement include an enhanced under-
standing of research [14] and a positive impact on one’s
health and well-being, e.g., by coming to terms with
one’s illness [13, 14]. Reported negative experiences of
PPI relates to being overlooked and underused, feeling
overwhelmed and not having been informed about the
objectives of involvement activities [13, 14, 16].
Long-term collaboration with patient representatives has
been proposed to increase the relevance, quality, and validity
of eHealth interventions [17, 18]. Still, patient involvement
in eHealth intervention research has, with a few exceptions
[19], been limited to the consultation level and involved pa-
tient representatives only on single occasions [20, 21]. Ex-
changing experiences of PPI and getting feedback from
patients and researchers can bring insights into why, how
and when patient and/or public involvement in research
brings the greatest benefits. Such evaluation efforts are en-
couraged as this “can improve the involvement process, spur
mutual learning, and change researchers’ mindsets and fu-
ture practice” [22]. To our knowledge, studies that take into
account the perspectives and experiences of both patient re-
search partners (PRPs) and researchers involved in long-
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term collaborative research are scarce. Furthermore, there is
a lack of studies on patient involvement in health research
that are co-conceived and co-conducted with PRPs. Thus,
the aim of this study was to explore the experiences of PRPs
and researchers engaged in a co-creative long-term collabor-
ation in cancer research (the Fex-Can project, see below). It
was of particular interest to capture their reflections on the
impact of patient involvement and to evaluate the collabor-
ation by including PRPs’ and researchers’ views on the forms
for collaboration. In doing so, we aimed to advance know-
ledge about what patient involvement works, in what con-
text and why.
Patient involvement in the fertility and sexuality
following cancer (Fex-can) project
The present study was conducted in the context of the
Fex-Can project. Besides investigating the prevalence of
fertility distress and sexual dysfunction in young adults
with cancer during the first 5 years following diagnosis,
(Wettergren L, Ljungman L, Micaux Obol C, Eriksson L,
Lampic C: Sexual dysfunction and fertility-related distress
in young adults with cancer over 5 years following diagno-
sis: study protocol of the Fex-can cohort study, unpub-
lished) the project aims to test the effect of a web-based
psycho-educational intervention on these problem areas
in a randomized controlled trial (RCT) [23]. The collabor-
ation between researchers and PRPs is a core feature of
the Fex-Can project. This collaboration commenced in
2014 and was planned to continue over the five-year
course of the intervention development and evaluation.
The present study focuses on the experiences of the PRPs
and researchers involved in this long-term collaboration.
Patient research partners (PRPs)
Ten former patients treated for cancer and two signifi-
cant others of the same target group were recruited from
a previous study investigating sexuality and fertility
among survivors of childhood cancer [24], and through
cancer nurse navigators at a university hospital. A more
detailed description of the recruitment of the PRPs has
been reported previously [25]. All PRPs agreed to par-
ticipate in a five-year-long collaboration within the Fex-
Can project. The number recruited was based on the
belief of a suitable group size of at least 5–8 participants
at gatherings, taking into account absence at occasional
meetings as well as attrition (dropout) from the project.
All PRPs were born in Sweden, they lived in different
parts of the country and the majority had a university
degree. They worked or studied in various fields but
none of them had a background in healthcare or health-
related research. The former patients, six women and
four men, had been diagnosed in adolescence or young
adulthood and were aged 20–41 at recruitment. The sig-
nificant others were two mothers of teenagers who had
undergone cancer treatment. During the collaboration
the PRPs had been reimbursed for travel expenses and
accommodation, and were paid for their participation in
project meetings and time working with assignments.
Research group
The group included senior and junior researchers with
academic backgrounds in nursing, medicine, psychology
and psychiatry. Clinical backgrounds of the research
group members included primary care, psychotherapy,
and counselling in cancer care and sexually transmissible
infections. The research group members are from now
on referred to as ‘researchers’.
The forms for collaboration, including the length, fre-
quency and structure of meetings, were agreed upon dur-
ing the first meeting and were revisited on subsequent
meetings. The collaboration mainly took place in the form
of half-day meetings on a regular basis, while communica-
tion between these meetings was carried out by email. An
overview of the collaboration in the Fex-Can project is
presented in Table 1. The research group was responsible
for managing the collaboration with the PRPs, including
strategic and logistic planning of meetings with the PRPs.
The meetings were scheduled to ensure that the PRPs al-
ways were in majority at the gatherings that included
plenary and small group discussions as well as individual
assignments. The working relationship has covered differ-
ent activities and included the development of the web-
based psycho-educational intervention using a co-creative
design. The process was performed according to the de-
sign steps in the holistic framework by van Gemert-Pijnen
and colleagues [26]. For example, the PRPs were pre-
sented with suggestions and samples of intervention
material, which were discussed in detail and revised
and refined for presentation at subsequent meetings.
Aspects regarding e.g., graphical design of the website,
study procedure and design, and outcome measures
were also discussed and refined in cycles. A more de-
tailed description of the PRP’s impact on the content,
system, and service quality of the planned intervention
can be found in a previous publication by Winterling
and colleagues [25]. In addition, some PRPs contrib-
uted to the web-based intervention with their personal
stories, and one PRP participated as moderator of the
discussion forum during the RCT.
Methods
Design
The aim and procedures of the present study were
jointly decided at a scheduled patient involvement meet-
ing in March 2018, where five of the PRPs and three of
the researchers participated. Based on a discussion at a
previous patient involvement meeting, the meeting
included a work-shop on the possibility to share our
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common experiences of the research collaboration at an
international scientific conference. In an open and
creative discussion, the group decided to conduct an
interview study to gain deeper understanding of the
motivations for and experiences of the long-term collab-
oration among all involved PRPs and researchers.
The reporting abides by the Guidance for Reporting
Involvement of Patients and the Public (GRIPP2) (see
additional file) [27].
Participants
Of the 12 PRPs, one chose not to participate in the
interview study due to personal circumstances, leaving
11 participating PRPs (4 men, 7 women; 9 former pa-
tients and 2 mothers of former patients). Of a total of
nine researchers who had been involved in the collabor-
ation with the PRPs, those six persons who had partici-
pated in ≥4 patient involvement meetings were
approached for the present interview study and all
agreed to participate (1 man, 5 women).
Data collection
The researchers and PRPs at the above-mentioned meet-
ing developed an interview guide covering topics identi-
fied as relevant (Table 2). In order to optimize free
expression of experiences, it was agreed that all inter-
views should be conducted by the PRPs, and four of
those present at the meeting volunteered to this task.
The group decided that the researchers should provide
the necessary structure. This entailed mailing informa-
tion about the study aim, procedures and interview
questions to all PRPs and researchers, and explaining
the voluntary nature of participation. The researchers
also provided the four PRPs who would be conducting
the interviews with a work plan with clear instructions,
contact information to assigned interviewees, as well as
digital tools for recording of telephone interviews. This
study was part of the Fex-Can project, which was pro-
vided ethical approval in November 2013 by the Swedish
Ethical Review Authority (reference number: 2013/
1746–31/4). All participants provided verbal informed
consent to participate in this study.
The participants took part in semi-structured tele-
phone interviews. Thirteen individual interviews and two
dyadic interviews, in which two PRPs interviewed each
other on the same occasion, were conducted. With the
exception of two interviews, all were conducted by the
four PRPs who volunteered to this task. For practical
reasons, two individual interviews were performed by a
psychologist in the research team who had no prior rela-
tionship with the participants. The interviews were car-
ried out between April and June 2018. On average they
were 20min long, and all were audio-recorded and tran-
scribed verbatim. The interviewers also took field notes
during the interview.
Analysis
The PRPs and researchers at the above-mentioned meet-
ing decided that the researchers should have the main
responsibility for the analysis of the interview data. The
first author (EH), who was not part of the research
group and who had no relationships with the partici-
pants (PRPs or researchers) prior to the commencement
of the study, conducted the analysis. The transcripts
were analysed using qualitative content analysis, as de-
scribed by Graneheim and Lundman [28]. The analysis
followed the following steps: (1) each transcript was read
to gain an overall understanding of its context and con-
tent; (2) meaning units were identified, defined as sec-
tions that shared a common meaning and context
related to thoughts on the collaboration; and (3) mean-
ing units were assigned a descriptive code, defined as a
label of the meaning unit’s content. Codes were trans-
ferred into sub-categories which were sorted into cat-
egories, characterised as a group of content that shares a
commonality. An example of the analysis process is
shown in Table 3.
Table 1 Overview of first four years of patient involvement in the Fex-Can project
Patient involvement meetings PRPs Researchersa
Half-day meetings on Saturdays, including lunch 10 former patients
2 mothers of former patients
9 senior researchers, postdocs, doctoral students
2–3 meetings yearly, total of 10 meetings Median number PRPs at each meeting: 7 Median number researchers at each meetingb: 5
Each PRP attended a median of 5 meetings Each researcher attended a median of 7,5 meetings
PRPs: Patient research partners
a The composition and number of research group members varied over the collaboration period
b including two senior researchers (project leaders) who both attended all but one meeting
Table 2 Interview guide
Why did you join the collaboration?
How have you participated?
What does the collaboration mean to you?
How have patient research partners contributed to the project?
What do you think works in the collaboration?
Why do you think it works?
What could work better or be done differently?
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The first and last two authors held repeated meetings dur-
ing the course of the analysis, where they discussed the iden-
tified meaning units, codes, and overarching sub-categories
and categories. When all interviews were analysed, one of
the PRPs who performed some of the interviews (the third
author) was invited to review the findings and share her re-
flections on whether the interviews were thoroughly covered
by the findings. At this point, all remaining authors judged
that the findings thoroughly portrayed the data.
Results
The analysis resulted in five overarching categories: Rea-
sons for investing in a long-term collaboration, Benefits of
participating, Improving the research, Elements of success
and Challenges and ways to improve. The categories and
sub-categories are presented in Table 4. In the following
results presentation, the term ‘participants’ is used to de-
note experiences described by both PRPs and re-
searchers. All participants were provided with an
individual study number and each quote is marked with
the participant’s role and number, e.g. PRP #5.
Reasons for investing in a long-term collaboration
From the perspective of both PRPs and researchers, the
main reason for investing in the long-term collaboration
was the desire to improve cancer care. Participants
described having the general idea that “when one has
the chance to help others one should”, and that investing
in this collaboration would mean that one’s own experi-
ences will be utilized. PRPs emphasized that their own
negative experiences of care and support after the cancer
diagnosis motivated them to join the collaboration in
the first place, offering an opportunity to voice and
address perceived shortcomings of care.
“I wanted to contribute to help improving the care of
future patients. It was something I could easily do to
help, where I together with the other PRPs have
unique competence.” (PRP #5).
Furthermore, PRPs described that the collaboration of-
fered an opportunity to get answers to questions about
the care and support they had received, and that they
still felt were unanswered. Another reason, reported by
both PRPs and researchers, was that the collaboration
concerned issues that they found engaging and interest-
ing. A specific factor that motivated PRPs to sign up for
the long-term collaboration was related to how the ar-
rangement of the collaborative work and their role in it
were presented when they were invited to the project. In
particular, they mentioned that the collaboration
sounded like a fun activity that also provided an oppor-
tunity to meet others with a history of cancer.
Benefits of participating
The participants emphasized that being involved in this
collaboration had provided personal benefits. Gaining
such benefits was described as unexpected by some of
the PRPs. They described the collaboration as a kind of
therapy that helped them in their adjustment and re-
habilitation. Getting something back from being in-
volved in the research project was described by PRPs as
a source for continued motivation and engagement. The
collaboration provided a setting where they were able to
give voice to their feelings and concerns, and exchange
experiences with others who had been affected by can-
cer. The collaboration made them realize that their feel-
ings, concerns and problems were not unique, but rather
something that many do experience, even persons with-
out a history of cancer. Furthermore, to voice their expe-
riences in the group gave some the confidence to share
experiences also outside the group. Another therapeutic
element for the PRPs was learning that there are sources
of help available for certain problems and/or concerns.
“I felt very alone with this concern, but as soon as
you started to open up you realized that there were
others who had the same problem but not related to
cancer.” (PRP #9).
Table 3 Example of the content analysis process
Meaning unit Code Sub-category Category
It has been good that the researchers have been there to develop a framework and to
move the dialogue on.
A thought-through and
clear structure
Clear yet
accommodating
structure
Elements
of success
I think it’s important that we have this openness and freedom. That you, that everyone
feels that you contribute when you can, and as much as you can, without demanding
too much from the individual.
Voluntary participation
It’s exciting that there are so many people that can think and feel so much. Still, I do
think we can have rather different views. It often goes rather “smoothly” but it can
also be a bit, that you have different opinions about things, and I think it’s fascinating
that it still works so well.
Different views are
expressed and handled
Open and
trustworthy
atmosphere
Well, we have this follow-up every six months to see how things have been going,
and the issues that you have suggested to maybe change or keep, that this has actu-
ally been done. So, it’s nice to see that what you say at the gatherings actually helps.
Feedback on how the
input is used
Input made a
difference
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“For me, it has been, it has actually been sort of a
rehabilitation journey.” (PRP #3).
The participants described the collaboration as educa-
tional and fun. They expressed that they had learned a lot
from the collaboration, for example about how PPI in re-
search actually works and what it entails. They also em-
phasized that they had enjoyed the collaboration and that
they often felt happy and energized after the meetings.
Furthermore, the PRPs described that they perceived their
contributions as important and meaningful. They men-
tioned that the collaboration had meant a lot them, and
that it felt good to contribute to this research project that
aimed to make a difference for future patients.
“Yes, it has meant very much to feel that my experi-
ences can be important to someone else. And that it
actually, the things that I felt were bad, that I get
the opportunity to participate and tell this to some-
one so that it can be better for someone else.” (PRP
#2).
Moreover, the researchers described the collaboration
as very meaningful, personally and professionally. Work-
ing together with the PRPs made them feel that they
were doing an important and relevant job, which moti-
vated them in their daily work within this research
project.
“Well, it’s always fun to meet people with different
experiences and, like, interact. I find it enriching
both for the research and for my work, and for me
personally as well.” (Researcher #3).
Improving the research
Both PRPs and researchers described that involving pa-
tient representatives was of great significance for the re-
search project. It was emphasized that the collaboration
contributed to making the research more relevant, ac-
ceptable and tailored to the target population. Specific-
ally, insights and perspectives of PRPs were important
for the development of the format and content of the
intervention. Moreover, the participants expressed that
the inclusion of PRPs helped incorporating a perspective
from outside the academia and research system.
“Well, it’s about contributing with this insider per-
spective or something. That they actually have their
own lived experience of what we are trying to under-
stand from the outside.” (Researcher #3).
Table 4 Categories and sub-categories of participants’ experiences of the co-creative collaboration
Category Sub-category
Reasons for investing in a long-term collaboration Negative experiences of information and care
Desire to improve cancer care
Engaging topics
Chance to get answers to own questions
The form for the collaboration attracted interest
Benefits of participating Participation as a kind of therapy
An educational and fun activity
My work feels relevant and meaningful
Improving the research Contributes to making the research project relevant, acceptable and tailored
A more thought-through research process
Indicates quality of the project
Elements of success Engaged and committed participants
Strive towards a common goal
Clear yet accommodating structure
Open and trustworthy atmosphere
Input made a difference
A diverse group
Nice and fun to meet
Good leadership
Challenges and ways to improve Greater diversity of group members
Alternative structure of collaboration to advance progress
Distance to meeting venue as an obstacle
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“It’s a way to, based on your own experiences, find
out how one can somehow improve the portal [the
web-based program] for example, so that it doesn’t
end up so, so confined or too research, research-
focused, but rather adapted to the actual issues one
is confronted with. / … / So I believe, adaptation
based on relevance rather than theory./ … / I think
it’s hard to relate to what it is one must face if you
haven’t been through it yourself.” (PRP #1).
It was described that more thought was given to the
research process thanks to the collaboration. For ex-
ample, researchers described that having research part-
ners involved in the project reminded them of the end
goal of the project in every step of the way.
“So that we don’t risk getting stuck in a sort of ‘re-
search mode’, that it’s exciting to explore things. But
here the aim is to improve the care / … / To con-
stantly remind us that this is the end goal so that we
don’t lose sight of that focus.” (Researcher #6).
Furthermore, the participants pointed out that having
established a collaboration with PRPs is an indicator of
quality of research, i.e., that patient involvement in itself
is a mark of quality of the research.
“We [the PRPs] have like significance to, for the re-
search project. Like a mark of quality, increased, yes,
simply an increased quality.” (PRP #4).
Elements of success
The participants had a genuine interest in the topic of
the research project and were engaged in whatever task
was at hand. This commitment to the collaboration
among both the researchers and PRPs was described as
a key factor for why the collaboration had worked well.
Moreover, having a common goal that all strived to-
wards was described as essential for sustaining the long-
term collaboration. To have a common goal that was
clear to all was regarded as the main link between the
participants.
“Well, we do have, I think it’s like everyone has a
common cause that binds us together.” (PRP #6).
Another element of success concerned the clear but
yet accommodating structure of the collaboration.
One important factor was the format for meetings
and assignments, which was open for discussion, and
that participants generally accepted and found prac-
tical. The clear distribution of roles between PRPs
and researchers, and the structure of providing recur-
rent feedback to PRPs on the progress of the project
and the implementation of their input, gave a sense
of stability. Another important factor was the finan-
cial compensation to PRPs for lost working hours and
travel expenses. Participants also acknowledged the
value of participation being voluntary, and appreciated
that one could invest as much as one wanted in the
collaboration, and be free to attend or be absent at
gatherings depending on availability.
“I think it works really well because, partly because
it’s once per semester. And that it’s like a whole day
so that it gets, or a full day, a few hours. So that it
gets pretty intense so, so that you really are
immersed in it.” (PRP #2).
“Well, I think it’s the clarity around the frame-
work, assignments, it’s clear. We provide the invi-
tation, the framework is clear, there’s an agenda,
there is this lunch, it’s sufficiently structured. And
that means we all trust in and feel confident to
continue this project with a very clear framework
and build on what we have said before. That you
believe what you have to say, or what you your-
self are interested in or feel is important, will be
made use of, because then there is reason to
come.” (Researcher #4).
The collaboration was characterised by an open and
trusting atmosphere, which was described as a key elem-
ent to a successful and sustainable collaboration. The
participants pointed out that all were encouraged to
share their experiences and opinions, regardless if posi-
tive or negative. When differing views were expressed
these were discussed in a respectful manner. The PRPs
furthermore recognized that they were treated as equals,
which contributed to an atmosphere of mutual respect,
empathy and trust.
“And then, when we meet, I think it works very well
because it’s an open atmosphere, and everyone is
very understanding and empathetic. So you can, you
don’t have to be afraid to say what you think and
feel, but it’s a very understanding atmosphere.” (PRP
#2).
The PRPs found it important to see that their input
was incorporated in the project, i.e. that their opinions
and suggestions actually made a difference. Receiving
feedback on how their input was utilized contributed to
a sense of meaningfulness.
“And you really feel that those who lead this project
listen to you and acknowledge what we say, regard-
less of whether it’s just one person saying it, they
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really take it into account. And that, for example,
the texts are revised based on that.” (PRP #2).
Participants described the value of diversity in the
group of PRPs, including both patient representatives
and significant others who differed in age, cancer experi-
ence and areas of residency. Furthermore, participants
mentioned that the size of the group was suitable. While
it was large enough to allow for different opinions and
experiences to be raised, it was small enough for every-
one to get to know each other and have their say. Partic-
ipants also mentioned that a smaller group would have
made the gatherings dependent on everyone showing
up.
“Well, there’s a variation of ages and different diag-
noses and everything, so I think, and from different
areas in the country, and I think that has also been
positive. So, not everyone has the same background,
in any way, not in terms of disease characteristics ei-
ther.” (PRP #7).
Moreover, when participants talked about what makes
the collaboration work well and keep participants com-
mitted, they expressed that the group members enjoyed
each other’s company and that the meetings were
enjoyable.
“It’s partly a coincidence, that it ended up being nice
people that have met, but I also think that the indi-
viduals, that we like being together, and that’s also
what makes, drives our collaboration and makes
everyone want, want to be part of this and return.”
(Researcher #1).
“Well, it has been a nice atmosphere, like in the
group and so. / … / we usually have some food and
so on at the meetings. So, that definitely contributes
to a more relaxed atmosphere rather than becoming,
like kind of stiff or something.” (PRP #9).
The PRPs explained how the leadership had been of
great importance for the successful collaboration. The
leadership was described as knowledgeable and keen. It
was mentioned that the meetings were perceived as
meaningful because the researchers had led the meetings
with such professionalism, e.g. by facilitating the discus-
sions on the focal topics.
“And then it doesn’t get like messy, but the re-
searchers keep it [discussions at patient involvement
meetings] under control so it goes smoothly, and I
think it’s done very professionally. It makes you feel
safe. / ... / And then, you feel important and the
researchers are very careful about showing that our
presence and input are important. You really get
that feeling.” (PRP #6).
Challenges and ways to improve
The participants described that the diversity of the group
could have been better. Group members of differing eth-
nicities, backgrounds and educational experiences might
have brought up different perspectives and important
experiences. Moreover, it was mentioned that the PRPs
contributed with important experiences and opinions to
the project, but few actually expressed major problems
with the issues that the intervention targeted.
“Sure, the ideal would have been to find persons who
were committed and also had a lot of problems.”
(Researcher #5).
“Possibly, if you want more different ethnicities or
something …” (PRP #9).
Alternative ways to organize the collaboration were
discussed in terms of how this might have advanced the
progress of the project. Suggestions included having
more frequent gatherings, having online meetings along-
side gatherings, and having the opportunity to work with
material from home. The researchers expressed ideas on
how to engage PRPs in other ways and in other tasks.
For example, having PRPs work part-time in the project,
and giving them the chance to freely come up with ideas
on how the research project should evolve. The partici-
pants mentioned that a potential drawback of long-term
collaborations is the risk that members will become less
objective and less critical over time. Furthermore, the
participants described how distance to the meeting
venue was an obstacle, and suggested that the time for
meetings should be prolonged since some travelled quite
far for the half-day meetings.
“Now it may be included somehow in this latest pro-
ject [the present study] but, well, one could have let
you [PRPs] control the agenda even more, regarding
what we should address, like what’s important.” (Re-
searcher #3).
“You could have virtual meetings, Skype or some-
thing. It would make it a little easier sometimes be-
cause ... when I attend a meeting, it takes like the
whole day, even if it [the meeting] is only half a
day.” (PRP #8).
Discussion
This exploration of PRPs’ and researchers’ experiences
of being involved in a four-year co-creative research
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collaboration offers unique insights into patient involve-
ment in eHealth intervention research, a relatively unex-
plored area. The study identifies factors important to
researchers and clinicians attempting to engage patients
in research. A variety of reasons for investing in a long-
term collaboration were described by the participants.
These reasons included the desire to improve cancer
care, getting the opportunity to make use of own nega-
tive experiences and to work with engaging topics. The
participants furthermore recognised personal benefits of
taking part in the collaboration and also acknowledged
positive impact of involvement on the research, such as
making the research more relevant, acceptable and tai-
lored to end users. A main finding of this study concerns
the elements of what makes a long-term research collab-
oration with patient involvement successful according to
the participants. Among the most prominent elements
were striving towards a shared goal, a structure of the
collaboration that was clear but yet accommodating, a
working atmosphere characterized by openness and
trust, and seeing that input made a difference, i.e. that
ideas and comments were implemented in the research.
The participants expressed overwhelmingly positive
views of the collaboration while few negative experiences
were reported.
To our knowledge, the present study is the first to
offer a comprehensive investigation of both PRPs’ and
researchers’ experiences of a long-term co-creative re-
search collaboration in eHealth intervention research. In
Sweden, patient involvement in research is emerging
with increasing numbers of researchers attempting to
engage patients in their work. By sharing the experiences
of PRPs and researchers involved in the Fex-Can collab-
oration we hope to provide guidance on how to set up
and enhance patient involvement in health research.
Furthermore, while studies on experiences of patient in-
volvement in cancer research do exist [11], we are not
aware of any such studies that have been conceived and
conducted together with PRPs. To truly explore the po-
tential of patient involvement, PRPs should indeed be in-
volved throughout the research process.
Increased understanding of PRPs’ motives for getting
involved in research and their expectations of such in-
volvement can inform researchers about ways to recruit
patient representatives and encourage their involvement.
The participants in the present study expressed altruistic
motivations for getting involved. For example, partici-
pants described that they were motivated to sign up for
the collaboration since it provided an opportunity both
to improve cancer care for future patients and to make
use of own negative experiences. This finding mirrors
results of studies on users and carers engaged in practi-
tioner education [29], in the National Cancer Research
Network in the UK [15], and in a variety of diagnostic
research specialties in the UK [14]. However, contrasting
the study by Ashcroft and colleagues [14], being moti-
vated to join for personal development reasons or for fi-
nancial gains was not reported by the present study
participants. Our findings suggest that patient represen-
tatives may not be fully aware at the outset that they can
gain personal benefits from being involved as PRPs.
Some participants reported that the proposed form for
collaboration seemed to be fun and offered an opportun-
ity to meet others with a history of cancer, which moti-
vated them to get involved. These findings emphasize
the importance of presenting the concept of patient in-
volvement, and the proposed format and purpose for the
research collaboration, in a clear and engaging manner.
We recommend that the forms for collaboration are dis-
cussed early on, in the first phase of the collaboration,
since we believe that this is a key factor for successful
patient involvement. Furthermore, such discussions can
be a good illustration of a working relationship on equal
grounds. This in turn can inspire both PRPs and re-
searchers, and open up for development of both the con-
tent of the research as well as suitable and feasible forms
and structure of the collaboration.
The participants in the study described various posi-
tive impacts of patient involvement on the research pro-
ject. The involvement of the PRPs was perceived to
contribute to creating a more thought-through research
process, constantly reminding the researchers of the
end-goal of the collaborative work. In line with what has
been shown in the literature on PPI in a range of health
and social care research [3, 5, 9, 30], the participants in
this long-term collaboration acknowledged that the PRPs
contributed by assessing the appropriateness of research
questions, study design, working material and outcome
measures. Furthermore, descriptions of the involvement
of the PRPs concerned how it facilitated the develop-
ment of a relevant and acceptable intervention tailored
to young adults with cancer. The concrete outcomes of
the PRPs’ impact on the development of the intervention
have been described previously [25]. A feasibility study
of this intervention showed promising results in terms
of demand, acceptability, preliminary efficacy, and func-
tionality [31]. The effectiveness of the interventions is to
be tested in a RCT trial [23].
Besides a positive impact on the research process, both
PRPs and researchers recognised personal benefits of be-
ing involved in a co-production of research. Personal
positive outcomes were reflected in PRPs’ statements of
therapeutic benefits, feeling useful and enjoyment of pa-
tient involvement activities. In accordance with previous
studies from the UK on involvement across mental
health trusts [16], in a variety of diagnostic research spe-
cialties [14], and in a cancer setting specifically [15], the
PRPs in this study described that the involvement had
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provided opportunities for personal development and
empowerment. The findings suggest that the involve-
ment provided them insights and means of meaning-
making. The psychological, social and intellectual per-
sonal benefits reported by the PRPs provide a nuanced
understanding of the wider implications of involvement.
To feel useful has previously been reported as a motiv-
ation for getting involved in research [14]. In line with
this, the PRPs in the present study mentioned their ex-
periences of making important and meaningful contribu-
tions to something useful for others as positive personal
outcomes. Participants described that it felt good that
their experiences and opinions were made use of, which
can be seen as an important motivation for participants
to stay involved over a long period of time. Furthermore,
consistent with previous studies conducted in the UK
with differing approaches of PPI [32, 33], our results
show that the researchers felt that involving PRPs was
valuable to them personally, beyond the impact on the
research process. They described that collaborating with
the PRPs was inspiring and contributed to the feeling of
doing important work. Overall, the experience of patient
involvement was seen as a positive part of their daily
work. In view of previous reports showing negative expe-
riences of PPI among researchers [33], the finding that
no strains or negative experiences were reported by the
researchers involved in this four-year collaboration is
notable and encouraging.
Our findings identified a range of factors associated
with effective patient involvement. We believe that these
factors are of particular importance for researchers in
countries like Sweden where the involvement of patient
representatives as collaborators in research is expanding,
but where there is a need to enhance the knowledge of
how to best work with PRPs [12, 34]. For increased
knowledge of how to successfully involve patients in re-
search, initiatives should come from the research com-
munity, health authorities as well as patient
organisations [12]. Internationally, the UK has been
leading in developing such initiatives for improving PPI
in health research. Examples include the government-
funded programme INVOLVE [35] and the James Lind
Alliance [36], which both work to bring together expert-
ise, insight and experience of PPI to advance the process
by which research is identified, prioritised, and con-
ducted. The results of this study showed that one key
factor for effective patient involvement was having a
clear but accommodating structure of the collaboration.
The participants expressed that the roles of the PRPs
and the researchers were clear to them, which is an im-
portant finding since the lack of clarity regarding expec-
tations and roles has been identified as a barrier to PPI
[14]. While the participants mentioned alternative ways
to work together, such as online meetings, it is clear
from our findings that both the PRPs and the re-
searchers valued having face-to-face meetings, which
allowed for social interactions and the building of rela-
tionships. Furthermore, our findings highlight the im-
portance of acknowledging the input from PRPs by
providing feedback on the value of their contribution,
which previously has been shown to be important in
maintaining motivation and confidence among PRPs
[37]. We recommend that researchers engaging in PPI
set in place a specific system to ensure that PRPs are
given recurrent feedback on how the research advances
and how their input is implemented in the research.
It should be noted that several of the elements that we
identified as important for successful collaboration may
be a result from the long-term nature of our collabor-
ation, with the same participants having been involved
for several years. This is in line with the National Insti-
tute for Health Research funded RAPPORT study [38],
which emphasizes establishment of relationships main-
tained over time as a key characteristic for effective PPI
that goes beyond the consultation level. The PRPs in the
present study emphasized the importance of having been
treated as equals for the success of creating an atmos-
phere of mutual respect, empathy and trust, which is
something that may take time to establish. Indeed, it has
been suggested that participation of PRPs on an equal
footing is a key for facilitating meaningful interactions
and knowledge exchange [39].
Despite probing questions about negative experiences
of the collaboration, very few negative comments were
made. Among the few challenges mentioned were dis-
tance to the meeting venues and a lack of diversity in
terms of race, education and perceived problems related
to the focus of the Fex-Can project. The group’s com-
position reflects a critical remark pointed out in a recent
systematic review on PPI in cancer research, namely the
apparent over-representation of well-educated female
participants from ethnic majority groups among public
and patient representatives [11]. It is clear that further
work is needed on how to engage under-represented
groups in PPI in health research. We recommend that
future studies work actively towards achieving diversity
among PRPs, using innovative strategies for recruitment.
Different approaches to attract and connect with new
members should be tested. One example we have dis-
cussed within our collaboration is to have experienced
PRPs act as mentors for new PRPs.
Strengths and limitations
A main strength of the present study is that the study
was conceived, conducted and disseminated by a group
of five PRPs and three researchers. The preliminary re-
sults of the study were jointly compiled by this group
and presented at the International Society of Quality of
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Life (ISOQOL) conference in 2018 [40]. We believe that
the active involvement of PRPs in designing the study,
collecting the data, reviewing the findings, and dissemin-
ating the results increases the authenticity and trust-
worthiness of the findings. Based on their significant
contributions, all PRPs were offered co-authorship on
this paper. Another strength of this study is that the in-
terviews yielded data on a diverse range of views and ex-
periences of the collaboration. Furthermore, we believe
that the credibility of the results is strengthened by the
fact that the analysis was led by an external researcher
with no previous involvement in the Fex-Can project.
Still, some limitations should be considered when inter-
preting the results of this study. Even though the partici-
pants emphasized that the collaboration was
characterized by an open atmosphere where both posi-
tive and negative comments were welcomed, we cannot
rule out the possibility that some may have felt reluctant
to speak critically about the collaboration during the in-
terviews. The potential influence of power dynamics on
patient involvement is a well-known challenge [41]. One
strategy to counter this in the present project was to en-
sure that PRPs were in the majority at all meetings. Fur-
thermore, the study interviews were conducted by PRPs
with the ambition to create an atmosphere where the
participants would feel comfortable in expressing their
feelings and thoughts about the collaboration. However,
we must acknowledge the risk of researchers not feeling
comfortable to express negative thoughts about the col-
laboration with PRPs.
Conclusions
By taking into account both the PRPs’ and re-
searchers’ experiences of being involved in a four-year
co-creative research collaboration, our results inform
practice by identifying factors that facilitate successful
and meaningful patient involvement in a research set-
ting. This study highlights that the purpose and for-
mat of the collaboration should be clear both with
regard to content, and the roles and expectations of
PRPs and researchers. A clear but yet accommodating
structure and a keen leadership emerged as key fac-
tors in creating a sense of stability and a trustful at-
mosphere. Furthermore, the results of this study
underscore that providing regular feedback on how
PRPs’ input is implemented in the research increases
the likelihood of PRPs remaining committed in a
long-term research collaboration. A central aspect of
the present study is that it was conceived, designed
and conducted in collaboration with PRPs. We en-
courage future studies of patient involvement to be
conducted in a similar co-creative manner, extending
the work with PRPs to include all stages in a research
project.
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